Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Machine learning-based imaging biomarkers improve statistical power in clinical trials

View ORCID ProfileCarolyn Lou, View ORCID ProfileMohamad Habes, View ORCID ProfileChristos Davatzikos, View ORCID ProfileRussell T. Shinohara, Alzheimer’s Disease Neuroimaging Initiative
doi: https://doi.org/10.1101/19010041
Carolyn Lou
aPenn Statistics in Imaging and Visualization Center, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, 423 Guardian Drive, Philadelphia, PA, 19104
bCenter for Biomedical Image Computing and Analytics, Department of Radiology, University of Pennsylvania, 3700 Hamilton Walk, Philadelphia, PA, 19104
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carolyn Lou
Mohamad Habes
bCenter for Biomedical Image Computing and Analytics, Department of Radiology, University of Pennsylvania, 3700 Hamilton Walk, Philadelphia, PA, 19104
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mohamad Habes
Christos Davatzikos
bCenter for Biomedical Image Computing and Analytics, Department of Radiology, University of Pennsylvania, 3700 Hamilton Walk, Philadelphia, PA, 19104
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christos Davatzikos
  • For correspondence: christos.davatzikos@pennmedicine.upenn.edu rshi@pennmedicine.upenn.edu
Russell T. Shinohara
aPenn Statistics in Imaging and Visualization Center, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, 423 Guardian Drive, Philadelphia, PA, 19104
bCenter for Biomedical Image Computing and Analytics, Department of Radiology, University of Pennsylvania, 3700 Hamilton Walk, Philadelphia, PA, 19104
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Russell T. Shinohara
  • For correspondence: christos.davatzikos@pennmedicine.upenn.edu rshi@pennmedicine.upenn.edu
  • For correspondence: christos.davatzikos@pennmedicine.upenn.edu rshi@pennmedicine.upenn.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Radiomic models, which leverage complex imaging patterns and machine learning, are increasingly accurate in predicting patient response to treatment and clinical outcome on an individual patient basis. In this work, we show that this predictive power can be utilized in clinical trials to significantly increase statistical power to detect treatment effects or reduce the sample size required to achieve a given power. Akin to the historical control paradigm, we propose to utilize a radiomic prediction model to generate a pseudo-control sample for each individual in the trial of interest. We then incorporate these pseudo-controls into the analysis of the clinical trial of interest using classical and well established statistical tools, and investigate statistical power. Effectively, this approach utilizes each individual’s radiomics-based predictor of outcome for comparison with the actual outcome, potentially increasing statistical power considerably, depending on the accuracy of the predictor. In simulations of treatment effects based on real radiomic predictive models from brain cancer and prodromal Alzheimer’s Disease, we show that this methodology can decrease the required sample sizes by as much as a half, depending on the strength of the radiomic predictor. We further find that this method is most helpful when treatment effect sizes are small and that power grows with the accuracy of radiomic prediction.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported in part by NIH grants R01NS085211, R01MH112847, R01NS060910, RF1AG054409, R01EB022573, R01NS042645, and R01MH112070.

Author Declarations

All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.

Not Applicable

I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.

Yes

Footnotes

  • R.T.S. and C.D. designed research; C.L. performed research; C.L. and M.H. analyzed data; and C.L., M.H., R.T.S., and C.D. wrote the paper.

  • The authors declare no conflict of interest.

  • Data used in preparation of this article were obtained from the ADNI database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report.

  • ∗ The ADNI was launched in 2003 as a public-private partnership, led by Principal Investigator Michael W. Weiner, MD. For up-to-date information, see www.adni-info.org.

Data Availability

All SPARE-AD scores used herein have been uploaded to http://adni.loni.ucla.edu/. All image processing software used to derive SPARE-AD, importantly the DRAMMS deformable registration and COMPARE classification pipelines, are freely available for download under http://www.rad.upenn.edu/sbia, and involve fully automated procedures. Data for the GBM analysis are not publicly available.

http://adni.loni.ucla.edu/.

http://www.rad.upenn.edu/sbia

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted November 12, 2019.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Machine learning-based imaging biomarkers improve statistical power in clinical trials
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Machine learning-based imaging biomarkers improve statistical power in clinical trials
Carolyn Lou, Mohamad Habes, Christos Davatzikos, Russell T. Shinohara, Alzheimer’s Disease Neuroimaging Initiative
medRxiv 19010041; doi: https://doi.org/10.1101/19010041
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Machine learning-based imaging biomarkers improve statistical power in clinical trials
Carolyn Lou, Mohamad Habes, Christos Davatzikos, Russell T. Shinohara, Alzheimer’s Disease Neuroimaging Initiative
medRxiv 19010041; doi: https://doi.org/10.1101/19010041

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Radiology and Imaging
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (435)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9018)
  • Forensic Medicine (4)
  • Gastroenterology (422)
  • Genetic and Genomic Medicine (1964)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1333)
  • Health Policy (662)
  • Health Systems and Quality Improvement (522)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10832)
  • Intensive Care and Critical Care Medicine (576)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (223)
  • Neurology (1842)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (358)
  • Occupational and Environmental Health (470)
  • Oncology (1006)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (184)
  • Pain Medicine (126)
  • Palliative Medicine (45)
  • Pathology (267)
  • Pediatrics (583)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4137)
  • Radiology and Imaging (678)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (110)
  • Urology (82)